AAAAAA

   
Results: 1-14 |
Results: 14

Authors: KOTLOFF KL WASSERMAN SS RUSS K SHAPIRO S DANIEL R BROWN W FROST A TABARA SO SHAH K
Citation: Kl. Kotloff et al., DETECTION OF GENITAL HUMAN-PAPILLOMAVIRUS AND ASSOCIATED CYTOLOGICAL ABNORMALITIES AMONG COLLEGE-WOMEN, Sexually transmitted diseases, 25(5), 1998, pp. 243-250

Authors: PERRY RT PLOWE CV KOUMARE B BOUGOUDOGO F KOTLOFF KL LOSONSKY GA WASSERMAN SS LEVINE MM
Citation: Rt. Perry et al., A SINGLE-DOSE OF LIVE ORAL CHOLERA VACCINE CVD 103-HGR IS SAFE AND IMMUNOGENIC IN HIV-INFECTED AND HIV-NONINFECTED ADULTS IN MALI, Bulletin of the World Health Organization, 76(1), 1998, pp. 63-71

Authors: VISCIDI RP KOTLOFF KL CLAYMAN B RUSS K SHAPIRO S SHAH KV
Citation: Rp. Viscidi et al., PREVALENCE OF ANTIBODIES TO HUMAN PAPILLOMAVIRUS (HPV) TYPE-16 VIRUS-LIKE PARTICLES IN RELATION TO CERVICAL HPV INFECTION AMONG COLLEGE-WOMEN, Clinical and diagnostic laboratory immunology, 4(2), 1997, pp. 122-126

Authors: TACKET CO KOTLOFF KL LOSONSKY G NATARO JP MICHALSKI J KAPER JB EDELMAN R LEVINE MM
Citation: Co. Tacket et al., VOLUNTEER STUDIES INVESTIGATING THE SAFETY AND EFFICACY OF LIVE ORAL EL-TOR VIBRIO-CHOLERAE-01 VACCINE STRAIN CVD-111, The American journal of tropical medicine and hygiene, 56(5), 1997, pp. 533-537

Authors: IYENGAR S SHAH KV KOTLOFF KL GHIM SJ VISCIDI RP
Citation: S. Iyengar et al., SELF-ASSEMBLY OF IN VITRO-TRANSLATED HUMAN PAPILLOMAVIRUS TYPE-16 L1 CAPSID PROTEIN INTO VIRUS-LIKE PARTICLES AND ANTIGENIC REACTIVITY OF THE PROTEIN, Clinical and diagnostic laboratory immunology, 3(6), 1996, pp. 733-739

Authors: BASHAM LE PAVLIAK V LI XR HAWWARI A KOTLOFF KL EDELMAN R FATTOM A
Citation: Le. Basham et al., A SIMPLE, QUANTITATIVE, REPRODUCIBLE AVIDIN-BIOTIN ELISA FOR THE EVALUATION OF GROUP-B STREPTOCOCCUS TYPE-SPECIFIC ANTIBODIES IN HUMANS, Vaccine, 14(5), 1996, pp. 439-445

Authors: KOTLOFF KL FATTOM A BASHAM L HAWWARI A HARKONEN S EDELMAN R
Citation: Kl. Kotloff et al., SAFETY AND IMMUNOGENICITY OF A TETRAVALENT GROUP-B STREPTOCOCCAL POLYSACCHARIDE VACCINE IN HEALTHY-ADULTS, Vaccine, 14(5), 1996, pp. 446-450

Authors: KOTLOFF KL
Citation: Kl. Kotloff, HELICOBACTER-PYLORI AND GASTRODUODENAL DISORDERS - NEW APPROACHES FORPREVENTION, DIAGNOSIS AND TREATMENT, Vaccine, 14(12), 1996, pp. 1174-1175

Authors: KOTLOFF KL NORIEGA F LOSONSKY GA SZTEIN MB WASSERMAN SS NATARO JP LEVINE MM
Citation: Kl. Kotloff et al., SAFETY, IMMUNOGENICITY, AND TRANSMISSIBILITY IN HUMANS OF CVD-1203, ALIVE ORAL SHIGELLA-FLEXNERI-2A VACCINE CANDIDATE ATTENUATED BY DELETIONS IN AROA AND VIRG, Infection and immunity, 64(11), 1996, pp. 4542-4548

Authors: KOTLOFF KL LOSONSKY GA NATARO JP WASSERMAN SS HALE TL TAYLOR DN NEWLAND JW SADOFF JC FORMAL SB LEVINE MM
Citation: Kl. Kotloff et al., EVALUATION OF THE SAFETY, IMMUNOGENICITY, AND EFFICACY IN HEALTHY-ADULTS OF 4 DOSES OF LIVE ORAL HYBRID ESCHERICHIA-COLI SHIGELLA-FLEXNERI 2A VACCINE STRAIN ECSF2A-2, Vaccine, 13(5), 1995, pp. 495-502

Authors: KOTLOFF KL NATARO JP LOSONSKY GA WASSERMAN SS HALE TL TAYLOR DN SADOFF JC LEVINE MM
Citation: Kl. Kotloff et al., A MODIFIED SHIGELLA VOLUNTEER CHALLENGE MODEL IN WHICH THE INOCULUM IS ADMINISTERED WITH BICARBONATE BUFFER - CLINICAL-EXPERIENCE AND IMPLICATIONS FOR SHIGELLA INFECTIVITY, Vaccine, 13(16), 1995, pp. 1488-1494

Authors: FARLEY JJ LEVINE GJ KOTLOFF KL
Citation: Jj. Farley et al., CLOSTRIDIUM-DIFFICILE-ASSOCIATED DIARRHEA AMONG HIV+ CHILDREN, Pediatric research, 37(4), 1995, pp. 174-174

Authors: KOTLOFF KL JOHNSON JP NAIR P HICKMAN D LIPPINCOTT P WILSON PD CLEMENS JD
Citation: Kl. Kotloff et al., DIARRHEAL MORBIDITY DURING THE 1ST 2 YEARS OF LIFE AMONG HIV-INFECTEDINFANTS, JAMA, the journal of the American Medical Association, 271(6), 1994, pp. 448-452

Authors: WASSERMAN SS KOTLOFF KL LOSONSKY GA LEVINE MM
Citation: Ss. Wasserman et al., IMMUNOLOGICAL RESPONSE TO ORAL CHOLERA VACCINATION IN A CROSSOVER STUDY - A NOVEL PLACEBO-EFFECT, American journal of epidemiology, 138(11), 1993, pp. 988-993
Risultati: 1-14 |